Submit An Article

dennis lin

Home
dennis lin

Most Read
Latest Comments

Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
- Review
- January 10, 2023
Opening a new frontier in treating Parkinson’s disease
- Review
- November 11, 2022
AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
- Review
- June 9, 2022
PharmAust completes dosing first cohort for MND treatment, patients respond positively
- Review
- January 6, 2023
Is this the most hated company on the ASX?
- Review
- August 16, 2019

Latest Articles

- News
Bubs Australia rebounds in China after CEO fiasco, sees USA growth
Baby formula company Bubs Australia (ASX: BUB) has all but closed the chapter on its financial and legal troubles that underlined most of last year. In the USA, its weekly scan revenue exceeded $1.5 million per week, with over 24,000 tins sold. The number of tins sold increased by 10k to about 24k compared to
Read More
Public
- News
Bubs Australia founder and CEO forced out for alleged failure to comply with board directions
Just a month after Bubs Australia (ASX: BUB) announced that executive chairman Dennis Lin would be removed from the business, the baby milk formula company announced another shake up of its executive line up. Perhaps a foreseeable one, this time founder and CEO Kristy Carr was terminated from her position with immediate effect due to
Read More
Public
- News
Bubs lodges letter of intent with FDA to become a permanent seller in the USA
After a successful entry into the USA during their recent dairy crisis, infant nutrition and dairy specialist Bubs Australia (ASX: BUB) has lodged a letter of intent to continue selling six Bubs Infant Formula products in the country till October 2025 and beyond. The Australian Company is one of only eight infant formula manufacturers globally
Read More
Public

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.